As the world of digital healthcare continues to evolve, how have the latest innovations been adopted within your practice? With such rapid changes occurring everyday, it might be hard to identify exactly what changes these are. Read on to discover seven key shifts in health tech (with a focus in dermoscopy/dermatology).
As artificial intelligence in dermatology continues to make leaps and bounds, there is an increasing need for additional literature citing the efficacy of intelligent machines in comparison to humans. One such study tested the performance of a convolutional neural network to aid in melanoma detection against a large group of dermatologists. This article looks to examine the applications behind the results of this study and the impact intelligent dermatology software will have on the industry.
With all of MetaOptima's recent accomplishments, we wanted to take this opportunity to talk a little bit about our vision. At its core, we work to empower medical professionals and patients with intelligent tools to promote the early detection of skin cancer and optimized care. With both increasing rates of skin cancer and breakthroughs in AI/artificial intelligence, we'd like to share more about MetaOptima's vision in the fight against melanoma starting with Australia.
Funds will be used to implement and build its intelligent dermatology platform DermEngine into the global dermatology industry beginning with Australia.
MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed.
MetaOptima is pleased to announce that DermEngine™, the world’s most advanced skin imaging and analytics tool, has officially been launched in Australia, marking an important advance in the way skin cancer is screened, tracked and detected.
Recently, MetaOptima received a $6.5 million USD ($8.6 million CAD) investment from Australian-based company Skip Capital, co-founded by Atlassian’s Scott Farquhar and Kim Jackson, along with venture capital firm AirTree led by co-founder Daniel Petre.
Within your practice you likely have a wide variety of systems at your disposal, each performing their own specific task. Although each software (ideally) performs its job efficiently, how well do they work with one another to support your practice?
As you go about your daily workflow, it is likely you deal with a wide variety of systems (perhaps an EMR software, dermoscopy analytics tools, teledermoscopy software, total body photography, clinical decision support tools to name a few).
Happy Birthday Canada! We’d like to celebrate today by sharing our appreciation for the Canadian government programs for all of their contributions towards new and growing companies like MetaOptima. With so many wonderful accomplishments, we’d like to take this opportunity to talk about how amazing Canada is for building innovative technologies that will have a global impact!
As the rates of skin cancer continue to rise in Canada, many family physicians have become the front line of defense for the early detection of these cases.1 Unfortunately, GPs have less experience detecting cancerous lesions than their dermatologist counterparts. How can dermoscopy tools provide a solution to this growing dissonance?
In part 2 of the article we discussed the cost efficacy of emerging cloud-based EMR software in contrast to the aging method of on-premise systems. The third and final step to completing this comparison is examining the actual capabilities provided by each of their systems: namely, once they are installed how are they supporting medical professionals in their practice? As with the last two articles, this will be examined through the lens of the dermoscopy industry.
When doctors implement or expand their practice, they have the opportunity to purchase from a wide variety of EMR systems. However, systems such as cloud-based and on-premise software operate in such contrasting ways that it can be hard to weigh the benefits of each. Part 2 of our EMR analysis will research the cost barriers and long-term efficacy of each type with a particular focus in the dermatology industry.
Recently, there has been one question in particular on the mind of every healthcare professional: how can I keep patient data secure? As technology rapidly evolves, this concern becomes intrinsically related to how health tech such as EMR software are equipped to handle the tsunami of changes facing the digital healthcare industry, particularly in the area of medical images and, in our case, dermoscopy.
Today was the final day of the World Congress of Dermoscopy! Over the last three days, word spread fast about it being last day to receive 50% off their MoleScope II alongside 6 FREE months of DermEngine. Read on to see how you can still experience this intelligent dermatology software for yourself.
Even busier than yesterday, the second day of the World Congress of Dermoscopy (WCD) at Booth #22 was packed with attendees eager to receive a demonstration of how DermEngine and MoleScope II can support their practice. If you haven't already signed up, read on to learn how you can receive 6 FREE months of DermEngine right now!
Today marked the first day of WCD 2018! Off to a fantastic start, the MetaOptima Team had a productive first day demoing DermEngine (our intelligent dermatology software) and MoleScope II (our mobile dermoscope) at Booth #22. Read on to find out what users thought of the latest upgrades to DermEngine!
The world of dermoscopy is rapidly evolving as intelligent dermatology software, tools, and innovations flood the market. Read on to discover the 5 innovations dominating the industry and how they will enhance the way you provide your services.
If you search for "Artificial Intelligence in Dermatology" news, you will likely be bombarded with articles asking questions such as "Will AI Replace Doctors?" or making broad statements such as "See Why AI Is The Next Big Thing In Dermatology". But what does this all mean? How will AI actually become integrated into the dermoscopy industry, and what does it mean for healthcare professionals?
The MetaOptima Team is thrilled to announce that Skin Capital and AirTree Ventures have invested $US 6.5 million in our company to support our continued journey of creating and developing intelligent dermoscopy tools for smart skin imaging, analytics, management, and skin cancer early detection!
The MetaOptima Team is gearing up for the World Congress of Dermoscopy 2018! Less than 11 days away, the 2018 congress will be held in Thessaloniki, Greece from June 14th-16th. This year we have a special discount for those who visit our booth (#22). Read on to find out how you can get a 6-month DermEngine subscription for free and walk away with 50% off your MoleScope II!
We are excited to share that the MetaOptima Team is attending the Australasian Skin Cancer Congress from May 25th to 27th in Queensland, Australia. Additionally, last week AUS/NZ Sales Manager, Darren, CTO & Co-Founder, Majid Razmara, and CEO & Co-Founder, Maryam Sadeghi attended the Australasian College of Dermatology's 51st Annual Scientific Meeting from May 19th-22nd to network with key opinion leaders while discussing how intelligent dermatology software can support their practice.
MetaOptima is pleased to announce that its CEO and Co-Founder, Maryam Sadeghi has been officially announced as the newest member of the Mitacs Research Council, where her duties will include supporting the continued research and innovation of Mitacs events while building new ideas and opportunities for intelligent discussions.
This summer, members of the MetaOptima team will be travelling to Thessaloniki, Greece for the 5th annual World Congress of Dermoscopy! Although the conference is held from June 16th-18th, preparations are already well underway to get ready for this big event, where we will be showcasing the latest features of DermEngine and MoleScope II at Booth #22!
From May 14th-16th MetaOptima team members Jodi Rai and Karen Meohas will be showcasing MoleScope II (our mobile dermoscope) at the BC Tech Summit in Vancouver, Canada. In addition to demonstrating how MoleScope can support the practice of physicians, they will get to explore, learn, and discuss how tools powered by artificial intelligence (AI) and machine learning are enhancing the Canadian economy. Attending the BC Tech Summit? Visit us at the Wavefront booth today!
We are thrilled to announce that Maryam Sadeghi, CEO of MetaOptima will be speaking at Startup Grind's Women Leaders Event in Vancouver! Along with two other CEOs, Maryam will be chatting about the importance of developing intelligent dermoscopy tools in healthcare, and sharing her personal experience about the challenges and rewards of being a successful female CEO in the digital health supercluster industry here in British Columbia.
At New Zealand's Skin Cancer Symposium, dermatologists learned the latest news in dermoscopy, skin cancer and how intelligent dermatology software can support their practice. Here, our AUS/NZ Sales Director, Darren presented DermEngine's latest tools while offering an exclusive deal for attendees.
Cloud-based dermatology EMR software is set for rapid growth in the upcoming years. This article discusses the primary benefits of Cloud computing such as interoperability and data accessibility along with the challenges it must overcome for successful implementation.
Each year BC Business Magazine journeys to find the province's most innovative, hard-working, and impactful women in STEM careers (science, technology, engineering, & mathematics). We are proud to announce that our CEO and Co-Founder, Maryam Sadeghi was announced as BC's Most Influential Woman in Health Tech in 2018! We'd like to take this opportunity to congratulate her on this significant achievement and learn more about her journey to becoming a visionary leader in the field of digital health
We are excited to announce that MetaOptima Technology was announced as a winner of the Ready To Rocket contest in the area of Digital Health! We are truly honored to be recognized as one of the fastest-growing start ups in the health tech industry for our technologies (MoleScope, our mobile dermoscope and DermEngine, our intelligent dermatology software) and are thrilled to be a part of this alongside such innovative companies!
This year, MetaOptima applied to PwC's Vision to Reality (V2R) award program. Every year, PwC looks for the most forward-thinking organizations in the nation to join their vibrant community of innovators and become part of Canada's story. As part of the application/interview process, the MetaOptima Team is personally invited to join other applicants at the V2R pre-awards reception in Vancouver on Thursday, March 8th from 5:30 pm-9:00 pm at the Terminal City Club!
Recently, there has been a considerable amount of hype surrounding artificial intelligence (particularly in the field of dermatology), which primarily discusses the potential benefits/challenges of the technology along with expected release timelines. Today, we will be focusing on amazing technologies fueled by artificial intelligence (AI) in healthcare that are currently available to the dermatology industry and beyond. From here, efficacy, applications, and similarities between these innovatio
This month, British Columbia was chosen as one of five successful superclusters that will receive federal funding. Seen as a hub of Canadian invention, British Columbia's technology sector already generates $26 billion in annual revenue. With the support of federal government, ecosystems across Canada will flourish with innovation and economic growth, with a GDP growth of $15 billion over the next decade!
Starting June 15th, London Drugs Patient Care Pharmacists (PCPs) are available for one-on-one personal skin check appointments at select lower mainland London Drugs stores. During each clinical session, the PCPs will utilize Vancouver-based MetaOptima's non-invasive MoleScope device and will review the importance of the "ABCDE" method for mole checks.
The Honourable Judy M. Foote, Minister of Public Services and Procurement, today announced that the Government of Canada is investing in a made-in-Canada innovation that uses smartphones to help detect skin cancer.
Canadian company MetaOptima Technology Incorporated is one of five new companies to join MediCity, the UK’s rapidly-expanding innovation hub for consumer healthcare, medical technology, diagnostics and beauty products.
Designed to be user-friendly, Molescope guides the patient with educational materials and allows the high-quality images to be used by physicians, general practitioners and dermatology specialists for ongoing patient management.
A perfect example of the companies now starting to emerge from B.C.’s established biotechnology and life sciences industry is MetaOptima, which has developed and is marketing the MoleScope, a small device that attaches to a smartphone which can help patients and physicians track potentially cancerous moles.
A new device that attaches to your smartphone and uses high-definition imaging to help healthcare professionals assesses the health of your moles is being introduced this week at the 23rd World Congress of Dermatology in Vancouver, Canada.
Simon Fraser University PhD graduate Maryam Sadeghi will unveil MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of Dermatology conference in Vancouver June 9-13.
A Simon Fraser University spinoff company has developed an app and a tiny microscope attachment for smartphones that allows users to take, store and share high quality images of moles and other suspicious skin lesions.
Rocket Builders today released its thirteenth annual “Ready to Rocket” lists. These lists profile British Columbia technology companies that are best positioned to capitalize on the technology sector trends that will lead them to faster growth than their peers.
Created to bolster innovation in Canada’s business sector, the Build in Canada Innovation Program (BCIP) helps companies bridge the pre-commercialization gap by procuring and testing late stage innovative goods and services within the federal government before taking them to market.” MetaOptima Technology’s DermEngine has been selected as one of 5 Pre-qualified innovations within the Health Sciences from Call for Proposals 005 which closed in September 2014.
On June 11th, 2014, MetaOptima competed in Plug and Play's Startup Showdown 2.0 in Vancouver, BC. Dr. Maryam Sadeghi, CEO, impressed the panel of judges with her pitch and placed first overall, winning a $25,000 investment and 3 months of office space and mentorship in Silicon Valley. Congratulations to all the winners!
Atkins is leading an SFUled initiative that, in 2013, created MoleScope, a tiny microscope used with a smartphone that snaps images of skin moles, a precursor of skin cancer, which aﬄicts six million new patients every year around the globe. MoleScope soft-ware stores images of moles, allowing physicians to monitor changes over time.
[Translation] More than just a simple microscope, the MoleScope system offers numerous features on its mobile app. In fact, this smartphone-attachable microscope allows the user to upload their mole images to a secure server and analyze any suspicious spots. [...] Even better, MoleScope allows the user to send their updated files and images to their doctor for review.
Melanoma is an increasingly common skin cancer that can be fatal if detected in an advanced stage. Today, innovation in skin cancer detection is taking a very high-tech turn. Maryam Sadeghi, of Simon Fraser University Surrey, near Vancouver, Canada is developing a smartphone-attachable imaging device for skin cancer screening called “MoleScope”...
The fight against skin cancer is enlisting the help of smartphones to monitor suspicious moles thanks to a Simon Fraser University grad's venture idea. The Coast Capital Savings Venture Prize Competition awarded Maryam Sadeghi, creator of the MoleScope technology, the top prize of $3,000 on February 12 after she pitched judges her business plan...
The MoleScope and UV Canada app, developed by Vancouver scientist Maryam Sadeghi, are designed to help Canadians identify skin cancer early. The technology is used to capture and record photos of potentially-cancerous moles and then share these images with medical specialists using cloud-based technology...
MoleScope Featured in Globe and Mail Skin cancer is both common and potentially deadly, with risks increasing the longer it goes undetected. So it made little sense to Maryam Sadeghi that people can wait days, weeks or even months to find out if suspicious moles were something to worry about. So she created MoleScope, a...
Maryam Sadeghi, founder of an award-winning health technology company, MetaOptima Technology Inc., is SFU’s 2013 Entrepreneur of the Year. Sadeghi was among 10 young SFU inventors who pitched their businesses in a Dragon’s Den-style competition before a panel of industry experts at SFU Surrey Nov. 16-17. Sadeghi also leads SFU’s new Digital Health Hub, based...
MetaOptima Technology Inc, a health technology company created by Simon Fraser University researcher Maryam Sadeghi, has won a top prize in the 2013 BCIC New Ventures Competition. The company received a $40,000 Wavefront Wireless prize package, finishing one of 10 companies shortlisted from nearly 150 applicants in this year’s competition...
As the sun continues to beat down this summer, the risk of being outdoors with no protection continues to grow. And it’s not just the temperature that plays a factor, but the UV rays that are emitted from the sun. “The main cause of skin cancer is UV rays. Too much sun exposure can cause skin cancer,” says Maryam Sadeghi with MetaOptima...
NSERC Innovation Challenge Award Maryam Sadeghi, who received her PhD in Computing Science from SFU this year, has been awarded a 2012 NSERC Innovation Challenge Award (Honourable Mention) for her innovative use of artificial intelligence and mobile technologies to improve prevention and early diagnosis of skin cancer. Dr. Sadeghi completed her doctoral studies in SFU’s...
Maryam Sadeghi has developed unique solutions for the prevention and early diagnosis of skin cancer by taking advantage of artificial intelligence using low-cost devices armed with mobile technologies, such as smart phones, for tele-dermatology. Her team has developed and launched UV Canada—a free public health education app for sun protection...